Invokana® (canagliflozin) And Invokamet® (canagliflozin And Metformin) - Risk Of Lower Limb Amputation

INVOKANA and INVOKAMET Recall Summary Janssen Pharmaceuticals is recalling INVOKANA (canagliflozin) and INVOKAMET (canagliflozin and metformin) across Canada due to an increased risk of lower limb amputation in patients taking these diabetes medications. These drugs are used to treat type 2 diabetes. The recall affects all patients in Canada who have been prescribed these medications.

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2017-09-06

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/7016b83e-8960-4d2e-a24c-325d0e8717c0